Pairing bariatric procedure with diabetes drug increases weight loss
Mexico’s Caribbean coast at “imminent risk” of lockdown
14 May 2021Health outcomes differ between UK and US children with cystic fibrosis
14 May 2021Pairing bariatric procedure with diabetes drug increases weight loss
Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with the diabetes drug semaglutide can provide additional significant weight loss for patients who are not candidates for invasive weight-loss surgery, according to research that was selected for presentation at Digestive Disease Week (DDW) 2021.
